152 related articles for article (PubMed ID: 8471071)
1. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
Yee LK; Allegra CJ; Trepel JB; Grem JL
Biochem Pharmacol; 1992 Apr; 43(7):1587-99. PubMed ID: 1567480
[TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
Ford H; Cooney DA; Ahluwalia GS; Hao Z; Rommel ME; Hicks L; Dobyns KA; Tomaszewski JE; Johns DG
Cancer Res; 1991 Jul; 51(14):3733-40. PubMed ID: 1712247
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1994 Apr; 5(2):223-8. PubMed ID: 7519483
[TBL] [Abstract][Full Text] [Related]
5. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
Zhang H; Cooney DA; Zhang MH; Ahluwalia G; Ford H; Johns DG
Cancer Res; 1993 Dec; 53(23):5714-20. PubMed ID: 7694793
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.
Blaney SM; Balis FM; Grem J; Cole DE; Adamson PC; Poplack DG
Cancer Res; 1992 Jun; 52(12):3503-5. PubMed ID: 1596909
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
[TBL] [Abstract][Full Text] [Related]
8. Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia.
van den Berg AA; van Lenthe H; Busch S; de Korte D; Roos D; van Kuilenburg AB; van Gennip AH
Eur J Biochem; 1993 Aug; 216(1):161-7. PubMed ID: 8365402
[TBL] [Abstract][Full Text] [Related]
9. The roles of uridine-cytidine kinase and CTP synthetase in the synthesis of CTP in malignant human T-lymphocytic cells.
van den Berg AA; van Lenthe H; Busch S; de Korte D; van Kuilenburg AB; van Gennip AH
Leukemia; 1994 Aug; 8(8):1375-8. PubMed ID: 8057676
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Grem JL; Allegra CJ
Cancer Res; 1990 Nov; 50(22):7279-84. PubMed ID: 1699659
[TBL] [Abstract][Full Text] [Related]
11. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
Ford H; Driscoll JS; Hao Z; Dobyns KA; Rommel ME; Stowe E; Anderson JO; Plowman J; Waud WR; Johns DG
Biochem Pharmacol; 1995 Jan; 49(2):173-80. PubMed ID: 7840794
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of continuous infusion cyclopentenyl cytosine.
Politi PM; Xie F; Dahut W; Ford H; Kelley JA; Bastian A; Setser A; Allegra CJ; Chen AP; Hamilton JM
Cancer Chemother Pharmacol; 1995; 36(6):513-23. PubMed ID: 7554044
[TBL] [Abstract][Full Text] [Related]
13. Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy.
Verschuur AC; Van Gennip AH; Leen R; Muller EJ; Elzinga L; Voûte PA; Van Kuilenburg AB
Eur J Cancer; 2000 Mar; 36(5):627-35. PubMed ID: 10738128
[TBL] [Abstract][Full Text] [Related]
14. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
Gharehbaghi K; Zhen W; Fritzer-Szekeres M; Szekeres T; Jayaram HN
Life Sci; 1999; 64(2):103-12. PubMed ID: 10069488
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine.
Copp RR; Marquez VE
J Med Chem; 1991 Jan; 34(1):208-12. PubMed ID: 1992119
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
Moyer JD; Malinowski NM; Treanor SP; Marquez VE
Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
[TBL] [Abstract][Full Text] [Related]
17. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells.
Bierau J; van Gennip AH; Leen R; Caron HN; van Kuilenburg AB
FEBS Lett; 2002 Sep; 527(1-3):229-33. PubMed ID: 12220665
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclopentenyl cytosine on human SK-N-BE(2)-C neuroblastoma cells.
Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
Biochem Pharmacol; 1995 Jul; 50(2):277-9. PubMed ID: 7632174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]